NRx pharmaceuticals – Life Sciences Voice https://lifescivoice.com Life Sciences Voice | The leading resource for life sciences industry executives. Tue, 03 Aug 2021 19:34:14 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.1 https://lifescivoice.com/wp-content/uploads/2020/01/Life-Sciences-Voice-Favicon-favicon.ico NRx pharmaceuticals – Life Sciences Voice https://lifescivoice.com 32 32 NRx Pharma’s ZYESAMI™ approved for emergency use Covid critical care in Georgia https://lifescivoice.com/nrx-pharmas-zyesami-approved-for-emergency-use-covid-critical-care-in-georgia/ Tue, 03 Aug 2021 11:08:39 +0000 https://lifescivoice.com/?p=1995 As of July 27, a global biopharmaceutical company, NRx Pharmaceuticals, has announced that the Prime Minister of the Nation of Georgia, together with the Health Minister, have issued an Emergency Use Authorization (EUA) for injecting ZYESAMI (aviptadil) as a treatment for critical COVID-19 condition.
“Lead investigators from our ZYESAMI clinical trials are on their way to the Nation of Georgia and will be on the ground there within 24 hours to start teaching physicians how to administer ZYESAMI™ to some of the sickest of COVID patients,” said Prof. Jonathan Javitt, MD, MPH, Chief Executive Officer and Chairman of the Board of NRx. “The repeating ferociousness of this pandemic is of great concern, and we hope ZYESAMI™ can have a real-world impact, comparable to what we saw in our clinical trials.”
A significant increase in the COVID-19 cases on daily basis ̶ hospitalization of patients, especially in the hospital ICUs ̶ as seen by the doctors of Georgia, has led to the approval of the drug by the regulatory authority.
Dr. Ivane Chkhaidze, a leading pulmonary physician in Georgia and a member of the Association of Georgia Physicians Leadership Team, said, “This latest wave of COVID-19, brought on by the delta variant has medical professionals in Georgia working throughout each day and night trying to keep people breathing.” He further added, “We appreciate the Prime Minister and Minister of Health authorizing the use of ZYESAMI and offering Georgian physicians a new treatment to help people recover from this devastating virus.”
A team of physicians traveling to Georgia to train fellow doctors about the effects and administration of the drug, is headed by Dr. Javier Perez-Fernandez, a lead investigator in the Phase 2b/3 clinical trial of intravenous ZYESAMI, and critical care pulmonologist in Miami, Florida. 20 of the leading critical care physicians in the country are in the team of Georgian physicians who got trained first.
Initial doses of ZYESAMI™ will arrive within 24 hours in the Nation of Georgia. The discussions regarding the provision of the drug for the critical COVID-19 Georgian patients, are still undergoing with the Ministry of Health.

]]> NRx Pharmaceuticals signs deal for clinical trials of Israel’s homegrown Covid-19 vaccine https://lifescivoice.com/nrx-pharmaceuticals-signs-deal-for-clinical-trials-of-israels-homegrown-covid-19-vaccine/ Tue, 20 Jul 2021 22:34:56 +0000 https://lifescivoice.com/?p=1951 Israel Institute for Biological Research (IIBR), an institute run by Israel’s Defense Ministry, has signed a memorandum of understanding (MoU) with the NRx Pharmaceuticals. According to which Israel’s domestic COVID-19 vaccine will undergo clinical trials as revealed by a statement.

Brilife, the said vaccine, will be driven to complete its third-stage clinical trials by the NRx Pharmaceuticals. Tens of thousands of volunteers belonging to Ukraine, Georgia and Israel will take part for the said cause after which the company will work up the commercialization of the vaccine. The Israeli vaccine is currently undergoing its second-stage trials after the fruitful attainment of first one in December, 2020 by IIBR.

The Defense Minister of Israel, Benny Gantz, applauded this covenant considering it “an excellent news”. In one of his statements Gantz narrates, “I anticipate that with this agreement, we will be able to complete the development of the vaccine and enable Israel to produce vaccines independently, because as we have seen recently – the coronavirus is not going anywhere”.

]]>